Actively Recruiting

Age: 18Years +
All Genders
NCT05695638

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Led by Morten Ladekarl · Updated on 2024-01-31

3000

Participants Needed

1

Research Sites

778 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Proseq Cancer is a precision medicine program based on in-house whole exome sequencing (WES) and RNA sequencing. The approved protocol allows for biobanking, registration of clinical and laboratory data, and sharing of genomic data with the purpose of research, while fulfilling the Danish General Data Protection Regulation (GDPR) requirements. Patients are recruited from the North Denmark Region. Treatment can be offered on site if a targeted drug of a nationally approved indication is suggested by the national tumor board (NTB). If not, the patient may be treated in an available clinical protocol. If no approved drug or relevant protocol is available or feasible, treatment with a targeted drug used outside a clinical protocol is pursued.

CONDITIONS

Official Title

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Incurable, progressing and/or life-threatening cancer
  • Expected residual survival of at least 3 months
  • No efficient remaining standard treatment options
  • Patient recruited from the Region of Northern Jutland, Denmark
Not Eligible

You will not qualify if you...

  • WHO Performance Status greater than 2
  • Significant comorbidity, concurrent medication or laboratory values imposing an unacceptable risk at medical oncological treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Oncology, Aalborg University Hospital

Aalborg, Denmark, 9000

Actively Recruiting

Loading map...

Research Team

M

Morten Ladekarl, MD, DMSci

CONTACT

A

Anja Pagh, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here